Small noncoding RNA TY2 enhances efferocytosis and improves outcomes in a mouse model of sepsis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41610433.
- Also identified by DOI 10.1172/jci.insight.196153 and PMC identifier 13041665.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
TY2 is a drug based on a natural compound with potent anti-inflammatory effects. TY2 improved outcomes in mice with severe bacterial infection.
Medical subject headings
- Sepsis
- Phagocytosis
- RNA, Small Untranslated